IL22 and inflammatory bowel disease: In view of the possible mechanisms involved in MSCsPP treating murine IBD, we further applied RNA‐sequencing to reveal the heterogeneity between these two tissues‐derived MSCs and demonstrated that IL‐22 played an important role in the enhanced therapeutic effects of MSCsPP.